NUWE Stock Analysis: Buy, Sell, or Hold?
NUWE - Nuwellis, Inc. Common Stock
$3.26
0.46 (16.42%)
▲
5d:
+3.49%
30d:
+2228.43%
90d:
+171.65%
HOLD
MODERATE Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 13, 2026
29d
Get Alerted When NUWE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: NUWE is 9.4% above its trading range ($2.98). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: NUWE is 9.4% above its trading range ($2.98). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: NUWE is currently trading at $3.26, which is considered extended relative to its 30-day fair value range of $0.02 to $2.98.
Technical Outlook: Technically, NUWE is in a downtrend. The price is approaching resistance at $0.99. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 16.4% recently.
Market Sentiment: NUWE has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.00 (+292.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NUWE is in a downtrend. The price is approaching resistance at $0.99. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 16.4% recently.
Market Sentiment: NUWE has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.00 (+292.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.02 -
$2.98
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range (+9.4% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+16.4%)
- BULLISH: Trading 292.9% below Wall St target ($11.00)
- CAUTION: Extended 9.4% above its trading range - wait for pullback
Trading Range Analysis
30-Day Trading Range
$0.02 -
$2.98
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.13
Resistance Level
$0.99
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.44
Wall Street Target
$11.00
(+292.9%)
Revenue Growth (YoY)
26.2%
Earnings Growth (YoY)
-99.2%
Profit Margin
-217.2%
Share & Embed Analysis
Last updated: July 14, 2026 2:53 PM ET
Data refreshes hourly during market hours. Next update: 3:53 PM
Data refreshes hourly during market hours. Next update: 3:53 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NUWE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$74 | 64 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 61 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$386 | 62 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$239 | 63 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$98 | 57 HOLD |
